About 50 results
Open links in new tab
  1. Viscosupplementation for Knee Osteoarthritis - Rheumatology Advisor

    Mar 25, 2019 · Viscosupplementation is one of those treatment options. What is Viscosupplementation? Viscosupplementation is a medical procedure during which a gel-like fluid called hyaluronic acid is …

  2. Viscosupplementation is a medical procedure during which a gel-like fluid called hyaluronic acid is injected into the knee joint. Hyaluronic acid is a naturally occurring lubricant that allows for smoother …

  3. ACR and AAHKS to Release Guidelines for Optimal Timing of Total …

    Apr 5, 2023 · The ACR and AAHKS developed consensus-based recommendations for the optimal timing of performing TJA among patients with OA or osteonecrosis.

  4. Guidelines for Optimal Timing of Total Joint Arthroplasty for ...

    Oct 20, 2023 · When the efficacy of nonoperative treatments for osteoarthritis or osteonecrosis diminishes, patients often choose arthroplasty as a means to alleviate pain and restore function. …

  5. Superior Reduction in Osteoarthritis Knee Pain From Novel Hyaluronan ...

    May 18, 2017 · “Viscosupplementation with hyaluronan is a well-established treatment option for knee osteoarthritis. The goal of viscosupplementation is to reduce pain and improve viscoelasticity of …

  6. Ortho Dx: What grade of arthritis does this patient have?

    Aug 22, 2017 · Viscosupplementation, or hyaluronic acid injections, are gel-like injections for the knee that provide lubrication and pain relief for patients with knee arthritis.

  7. ACR Releases Guidance on Managing VEXAS Syndrome

    Sep 2, 2025 · The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome.

  8. Lorecivivint Shows Promising Efficacy for Managing Knee Osteoarthritis ...

    Nov 19, 2024 · Lorecivivint was effective for managing symptoms of moderate to severe knee OA while providing structural benefits.

  9. Conservative Management Options for Osteoarthritis

    Apr 25, 2016 · Osteoarthritis is one of the most common problems encountered in primary care, and conservative treatment can improve patients' quality of life.

  10. Current Biologic Therapies for EGPA Latest results Benralizumab, which targets the IL-5 receptor and elicits a natural killer cell- mediated antibody-dependent response against eosinophils, is being …